Xeno – evolution & current state
Richard N. Pierson (US)
Search Program
Search sessions, presentations, speakers, abstracts, and program topics.
Results for xeno
Sunday, September 20, 2026
Cockle Bay 1
Post-Graduate Course - Clinical Program
Post-Graduate Course - Clinical Program
Matching presentations
Darling Harbour
Plenary Session 1
Plenary Session 1
Chairs
Medhat Askar (US) · John J. Fung (US)
Monday, September 21, 2026
Darling Harbour
Plenary Session 2
Plenary Session 2
Matching presentations
Clinical xenotransplantation: Experience to date
Tatsuo Kawai (US)
Xenozoonosis, no worries!
Anoma Nellore (US)
Let’s start with hearts!
Richard N. Pierson (US)
Let’s start with islets!
Wayne J. Hawthorne (AU)
The ethics of new technology in xenotransplantation
Luz Padilla (US)
Panel Discussion
Discussion Period (AU)
Room C4.6
Patient-centered outcomes and psychosocial determinants in kidney transplantation: From digital health to life course impacts
Patient-centered outcomes and psychosocial determinants in kidney transplantation: From digital health to life course impacts
Chairs
Audrey Au Yong (GB) · Adem Safak (TR)
Parkside 1&2
Hansa BioPharma Corporate Lunch Symposium on Transplanting the untransplantable – Idefirix® (imlifidase), a breakthrough innovation for highly sensitised kidney transplantation
Hansa BioPharma Corporate Lunch Symposium on Transplanting the untransplantable – Idefirix® (imlifidase), a breakthrough innovation for highly sensitised kidney transplantation
Chair
Steve Chadban (AU)
The Gallery
Lunch and Learn Roundtable
Lunch and Learn Roundtable
Matching presentations
Infectious disease surveillance and management in clinical xenotransplantation
Jay Fishman (US)
Cockle Bay 2
Omics in transplantation 1
Omics in transplantation 1
Chairs
Ana Konvalinka (CA) · Carol Pollock (AU)
Hall 1-2
Poster Session 1
Poster Session 1
Matching presentations
Short-course anti-CD154 induction followed by tacrolimus maintenance sustains pig-to-cynomolgus kidney xenograft function
Sun Ae Hwang (KR)
Mycophenolic acid suppresses human monocyte-macrophage cytotoxicity against swine endothelial cells through guanosine depletion
Yusuke Yanagino (JP)
Human NK Cell Activation by Porcine cells Compared to Allogeneic Human Cells
Eunjee Oh (KR)
Novel RORγ inverse agonists: Dual-action therapy for promoting graft tolerance while inhibiting tumor growth
Jean Tchervenkov (CA)
Tuesday, September 22, 2026
Cockle Bay 2
Immunosuppression: Experimental and clinical
Immunosuppression: Experimental and clinical
Chairs
Jaeseok Yang (KR) · Raman Venkataramanan (US)
Room C4.4
The journey to clinical xenotransplantation
The journey to clinical xenotransplantation
Chairs
Leonardo Riella (US) · Evelyn Salvaris (AU)
Matching presentations
2025 Carl-Gustav Groth Xeno Prize for the paper on "Desensitization with Proteasome Inhibition and Costimulation Blockade Modulates the Xenoreactive Humoral Response in Nonhuman Primate Xenotransplantation"
Brendan P. Lovasik (US)
Development of the gene edited pigs to get us to the clinic
Peter Cowan (AU)
Avoiding dysregulation of the complement and coagulation-anticoagulation systems?
Richard N. Pierson (US)
The road to regulatory approval for clinical transplantation
Muhammad Mohiuddin (US)
Room C3.4-C3.5
Immunoregulation: Cell signalling 2
Immunoregulation: Cell signalling 2
Chairs
Kate Gartlan (AU) · Lucy Sullivan (AU)
Room C4.1
Overcoming immune barriers in xenotransplantation: From innate recognition to gene-edited graft compatibility
Overcoming immune barriers in xenotransplantation: From innate recognition to gene-edited graft compatibility
Chairs
Richard N. Pierson (US) · Peter Cowan (AU)
Matching presentations
Loss of Neu5Gc in donor erythrocytes unlocks species-specific innate checkpoints governing macrophage recognition in xenotransplantation
Wang Yi (CN)
Normothermic Machine Perfusion of Human Kidneys Using Triple-Knockout Pig Red Blood Cells
Shuangjin Yu (CN)
First Large-Cohort Study Profiling the Baseline Immunological Status for Xenotransplantation in Liver Transplant Candidates: Implications for Safe Bridging from Gene-Edited Pigs
Liaoran Wang (CN)
Antibody responses against swine leukocyte antigens contribute to early rejection after pig-to-monkey kidney xenotransplantation
Hao Feng (CN)
Preformed and De Novo Xenoreactive IgM Antibodies Contribute to Early Xenograft Loss in Pig-to-Monkey Kidney Xenotransplantation
Man Zhang (CN)
Sequential Allotransplantation After Failure of Pig-to-Rhesus monkey Kidney Xenotransplantation: A Case Report
Man Zhang (CN)
Flow cytometry immune profiling provides early detection of rejection of islet xenotransplants
Thanh Le (AU)
HLA E CD94 NKG2A pathway confers superior NK cell resistance compared to extensive multitransgenic modifications in porcine endothelial cells
Jonathan Schulz (DE)
Endothelial PlexinB2 suppresses human neutrophil activation in a humanized xenotransplantation model
Shuji Miyagawa (JP)
Hall 1-2
Poster Session 2
Poster Session 2
Matching presentations
Development of knock-in porcine cell lines expressing human immune genes under endogenous promoters for xenotransplantation
Dong Eon Kim (KR)
Fabrication and Functional Validation of Parathyroid Organoids for Xenotransplantation in Non-Human Primates: Therapeutic approaches to hypoparathyroidism
Eun Yeol Yang (KR)
CD40–CD154 costimulation blockade enables safe repeated xenotransfusion of genetically engineered porcine red blood cells in nonhuman primates
Hee Jung Kang (KR)
How the UAE’s Legal Framework is Driving a Model Organ Donation and Transplantation System in the Arab World
Maria Gomez (AE)
Wednesday, September 23, 2026
Room C3.4-C3.5
Insights into old and new therapeutics 2
Insights into old and new therapeutics 2
Chairs
Philip O'Connell (AU) · Zhejia Tian (DE)
Room C4.7
Advancing islet and stem cell transplantation: Immune modulation, bioengineering, and graft survival
Advancing islet and stem cell transplantation: Immune modulation, bioengineering, and graft survival
Chairs
Hanne Scholz (NO) · Gregory S. Korbutt (CA)
Room C4.11
Vascularized tissue engineering and organ-on-chip platforms for transplantation and organ replacement
Vascularized tissue engineering and organ-on-chip platforms for transplantation and organ replacement
Chairs
Maria Siemionow (US) · Subramania Iyer (IN)
Cockle Bay 1
Clinical Xenotransplantation has Arrived!
Clinical Xenotransplantation has Arrived!
Chairs
Wayne J. Hawthorne (AU) · Robert A. Montgomery (US)
Matching presentations
Understanding optimal genetic modification
Peter Cowan (AU)
Experience and immunosuppression for clinical xenotransplantation
Muhammad Mohiuddin (US)
Special challenges of lung xenotransplantation
Richard N. Pierson (US)
Clinical xenotransplantation: A new era through the eyes of patients and families
Macey L. Levan (US)